Roger K. Cady
Corporate Officer/Principal presso ALDER BIOPHARMACEUTICALS, INC.
Profilo
Roger K.
Cady is the founder of Primary Care Network, Inc. He is currently the Director of the National Headache Foundation and the Vice President-Neurology at Lundbeck Seattle BioPharmaceuticals, Inc. He was previously the Medical Director at Shealy Institute for Comprehensive Pain.
He received his undergraduate degree from Drake University and his doctorate from Mayo Medical School.
Posizioni attive di Roger K. Cady
Società | Posizione | Inizio |
---|---|---|
ALDER BIOPHARMACEUTICALS, INC. | Corporate Officer/Principal | 06/06/2016 |
National Headache Foundation | Director/Board Member | - |
Precedenti posizioni note di Roger K. Cady
Società | Posizione | Fine |
---|---|---|
Shealy Institute for Comprehensive Pain
Shealy Institute for Comprehensive Pain Medical/Nursing ServicesHealth Services Part of Cluster Technology Corp., Shealy Institute for Comprehensive Pain is a medical clinic for pain management. The private company is based in Springfield, MO. Shealy Institute for Comprehensive Pain was acquired by Cluster Technology Corp. on January 21, 1998. | Chief Tech/Sci/R&D Officer | - |
Primary Care Network, Inc.
Primary Care Network, Inc. Medical/Nursing ServicesHealth Services Primary Care Network, Inc. provides health care services. The company is headquartered in Springfield, MO. | Founder | - |
Formazione di Roger K. Cady
Drake University | Undergraduate Degree |
Mayo Medical School | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 4 |
---|---|
Shealy Institute for Comprehensive Pain
Shealy Institute for Comprehensive Pain Medical/Nursing ServicesHealth Services Part of Cluster Technology Corp., Shealy Institute for Comprehensive Pain is a medical clinic for pain management. The private company is based in Springfield, MO. Shealy Institute for Comprehensive Pain was acquired by Cluster Technology Corp. on January 21, 1998. | Health Services |
Primary Care Network, Inc.
Primary Care Network, Inc. Medical/Nursing ServicesHealth Services Primary Care Network, Inc. provides health care services. The company is headquartered in Springfield, MO. | Health Services |
Lundbeck Seattle BioPharmaceuticals, Inc.
Lundbeck Seattle BioPharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Lundbeck Seattle BioPharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which focuses on transforming the migraine treatment paradigm through the discovery, development and commercialization of novel therapeutic antibodies. Its product includes Eptinezumab, is an investigational monoclonal antibody (mAb) that inhibits calcitonin gene-related peptide (CGRP) and is currently in late-stage clinical development for the prevention of migraine. The company was founded by Randall C. Schatzman, Mark J. Litton, and John A. Latham in January 2004 and is headquartered in Bothell, WA. | Health Technology |
National Headache Foundation |
- Borsa valori
- Insiders
- Roger K. Cady